Evidence map›Paper›PMID 38563448›Full record

ReviewImmunological reviews2024

Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation.

Raki Sudan, Susan Gilfillan, Marco Colonna

Open access · bronzeAbstract readReview
In one paragraph

Review in Immunological reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Innate Lymphoid Cells.Advances in experimental medicine and biology · 2025
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Raki SudanDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.
Susan GilfillanDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA.ORCID 0000-0001-5222-4987
Washington University in St. Louis · US

Funding

CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITYR01AI134035 · NIAID · WASHINGTON UNIVERSITY · PI MARCO COLONNA, Eugene M Oltz · 2018 to 2026
$4.8M
Mucosal Immune Defense Mechanisms of the Urinary BladderR01DK132327 · NIDDK · WASHINGTON UNIVERSITY · PI MARCO COLONNA, SCOTT J. HULTGREN · 2023 to 2026
$2.5M
Plasticity of Innate Lymphoid Cells: Mechanisms and Biological ImpactR01DK124699 · NIDDK · WASHINGTON UNIVERSITY · PI COLONNA, MARCO · 2020 to 2023
$1.4M
Determining the contribution of polyamine biosynthesis to the function of group 3 innate lymphoid cells in the gastrointestinal systemF30DK127540 · NIDDK · WASHINGTON UNIVERSITY · PI PENG, VINCENT · 2020 to 2022
$106k
NIAID NIH HHS R01 AI134035NIDDK NIH HHS F30 DK127540NIDDK NIH HHS R01 DK124699NIDDK NIH HHS R01 DK132327NIH HHS RO1AI134035NIH HHS RO1DK124699NIH HHS RO1DK132327
6 · The paper itself

Abstract

Group 1 innate lymphoid cells (ILCs), comprising ILC1s and natural killer cells (NK cells), belong to a large family of developmentally related innate lymphoid cells that lack rearranged antigen-specific receptors. NK cells and ILC1s both require the transcription factor T-bet for lineage commitment but additionally rely on Eomes and Hobit, respectively, for their development and effector maturation programs. Both ILC1s and NK cells are essential for rapid responses against infections and mediate cancer immunity through production of effector cytokines and cytotoxicity mediators. ILC1s are enriched in tissues and hence generally considered tissue resident cells whereas NK cells are often considered circulatory. Despite being deemed different cell types, ILC1s and NK cells share many common features both phenotypically and functionally. Recent studies employing single cell RNA sequencing (scRNA-seq) technology have exposed previously unappreciated heterogeneity in group 1 ILCs and further broaden our understanding of these cells. Findings from these studies imply that ILC1s in different tissues and organs share a common signature but exhibit some unique characteristics, possibly stemming from tissue imprinting. Also, data from recent fate mapping studies employing Hobit, RORγt, and polychromic reporter mice have greatly advanced our understanding of the developmental and effector maturation programs of these cells. In this review, we aim to outline the fundamental traits of mouse group 1 ILCs and explore recent discoveries related to their developmental programs, phenotypic heterogeneity, plasticity, and transcriptional regulation.

Indexed as

Cell PlasticityGene Expression RegulationImmunity, InnateKiller Cells, NaturalAnimalsCell DifferentiationCell LineageHumansLymphocytesLymphocyte SubsetsTranscription, GeneticheterogeneityILC1sILC developmentinnate lymphoid cellsNK cellsplasticitytranscription factors

Identifiers

PMID38563448
PMCPMC11102297
OpenAlexW4393410895

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.